The DNA Methylation is Involved in Liver Cancer Metastasis via Regulation of E- cadherin Gene.

Q2 Medicine
Asmahan S Kabel, Shaden M Hanafy, Mohamed F Elshal, Talaat Z Ibrahim, Hany Khalil
{"title":"The DNA Methylation is Involved in Liver Cancer Metastasis via Regulation of E- cadherin Gene.","authors":"Asmahan S Kabel, Shaden M Hanafy, Mohamed F Elshal, Talaat Z Ibrahim, Hany Khalil","doi":"10.31557/APJCP.2025.26.4.1371","DOIUrl":null,"url":null,"abstract":"<p><p>Over 90% of primary liver tumors are hepatocellular carcinomas (HCCs). In mammalian cells, chromatin remodeling and transcription regulation are significantly influenced by DNA methylation. Many cancers demonstrate both generalized DNA hypomethylation and localized DNA hypermethylation. Epithelial Cadherin (E-cadherin), a critical molecule in cell adhesion and cancer progression, is involved in these processes. This study aimed to investigate the biological role of DNA methyltransferase 1 (DNMT1) in HCC and its association with E-cadherin gene expression in HCC development. The study included 120 HCC patients from Egypt and 25 healthy individuals. Peripheral blood samples were collected from both groups, and quantitative real-time PCR was utilized to measure the expression levels of the E-cadherin and DNMT1 genes. All participants underwent a comprehensive medical history review and clinical examination. Additionally, the patients had laboratory tests, including serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), α-fetoprotein (AFP), albumin, serum creatinine, total leukocyte count (TLC), and platelet count. The results revealed significantly higher levels of these biochemical markers in the HCC group compared to the control group (P values < 0.005). Notably, DNMT1 expression was significantly higher in HCC samples compared to those from healthy controls. In contrast, the expression of E-cadherin was significantly reduced in the HCC group. Furthermore, our findings revealed that the relative gene expression of DNMT1 was negatively correlated with the relative gene expression of E-cadherin, AFP, and tumor size, while E-cadherin expression was negatively correlated with AFP and tumor size. These results suggest that DNMT1 may play a vital role in regulating E-cadherin expression, which could influence the migratory behavior of HCC cells.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 4","pages":"1371-1378"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12227960/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.4.1371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Over 90% of primary liver tumors are hepatocellular carcinomas (HCCs). In mammalian cells, chromatin remodeling and transcription regulation are significantly influenced by DNA methylation. Many cancers demonstrate both generalized DNA hypomethylation and localized DNA hypermethylation. Epithelial Cadherin (E-cadherin), a critical molecule in cell adhesion and cancer progression, is involved in these processes. This study aimed to investigate the biological role of DNA methyltransferase 1 (DNMT1) in HCC and its association with E-cadherin gene expression in HCC development. The study included 120 HCC patients from Egypt and 25 healthy individuals. Peripheral blood samples were collected from both groups, and quantitative real-time PCR was utilized to measure the expression levels of the E-cadherin and DNMT1 genes. All participants underwent a comprehensive medical history review and clinical examination. Additionally, the patients had laboratory tests, including serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), α-fetoprotein (AFP), albumin, serum creatinine, total leukocyte count (TLC), and platelet count. The results revealed significantly higher levels of these biochemical markers in the HCC group compared to the control group (P values < 0.005). Notably, DNMT1 expression was significantly higher in HCC samples compared to those from healthy controls. In contrast, the expression of E-cadherin was significantly reduced in the HCC group. Furthermore, our findings revealed that the relative gene expression of DNMT1 was negatively correlated with the relative gene expression of E-cadherin, AFP, and tumor size, while E-cadherin expression was negatively correlated with AFP and tumor size. These results suggest that DNMT1 may play a vital role in regulating E-cadherin expression, which could influence the migratory behavior of HCC cells.

DNA甲基化通过E-钙粘蛋白基因调控参与肝癌转移。
超过90%的原发性肝脏肿瘤是肝细胞癌(hcc)。在哺乳动物细胞中,染色质重塑和转录调控受到DNA甲基化的显著影响。许多癌症都表现出普遍的DNA低甲基化和局部的DNA高甲基化。上皮钙粘蛋白(E-cadherin)是细胞粘附和癌症进展的关键分子,参与了这些过程。本研究旨在探讨DNA甲基转移酶1 (DNMT1)在HCC中的生物学作用及其与E-cadherin基因表达在HCC发展中的关系。该研究包括来自埃及的120名HCC患者和25名健康人。采集两组小鼠外周血标本,采用实时荧光定量PCR检测E-cadherin和DNMT1基因的表达水平。所有参与者都进行了全面的病史回顾和临床检查。此外,患者还进行了实验室检查,包括血清丙氨酸转氨酶(ALT)、血清天冬氨酸转氨酶(AST)、α-胎蛋白(AFP)、白蛋白、血清肌酐、总白细胞计数(TLC)和血小板计数。结果显示,HCC组中这些生化标志物的水平明显高于对照组(P值< 0.005)。值得注意的是,与健康对照组相比,HCC样本中的DNMT1表达明显更高。相比之下,E-cadherin在HCC组的表达明显降低。此外,我们发现DNMT1的相对基因表达与E-cadherin、AFP、肿瘤大小呈负相关,而E-cadherin的相对基因表达与AFP、肿瘤大小呈负相关。这些结果提示DNMT1可能在调节E-cadherin表达中发挥重要作用,从而影响HCC细胞的迁移行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
779
审稿时长
3 months
期刊介绍: Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: -Epidemiology, detection and screening. -Cellular research and bio-markers. -Identification of bio-targets and agents with novel mechanisms of action. -Optimal clinical use of existing anti-cancer agents, including combination therapies. -Radiation and surgery. -Palliative care. -Patient adherence, quality of life, satisfaction. -Health economic evaluations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信